Please ensure Javascript is enabled for purposes of website accessibility

Why Clover Health Stock Sank Today

By Keith Speights - May 17, 2021 at 3:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors focused on the negatives with the company's first-quarter results more than the positives.

What happened

Shares of Clover Health Investments (CLOV 6.11%) were sinking 9.4% as of 3:10 p.m. EDT on Monday. The decline came after the Medicare-focused health insurer announced its first-quarter results

So what

The good news was that Clover Health reported record revenue of $200.3 million in the first quarter, up 21% year over year. However, based on the performance of the health insurance stock today, it appears that investors are focused more on the company's bad news.

Documents with "Medicare Advantage Plan" printed on the cover sheet

Image source: Getty Images.

Clover posted a Q1 net loss of $48.4 million, much worse than its net loss of $28.2 million in the prior-year period. Its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss also widened to $76.2 million in the first quarter of 2021 from $21.7 million in the same quarter of 2020.

In addition, the company's medical care ratio (MCR) -- the percentage of medical costs to premiums received -- increased to 107.6% from 89.4% in the year-ago period, based on generally accepted accounting principles (GAAP). Clover Health's normalized adjusted MCR was lower, however, coming in at 95.4%. The company believes that its MCR ratio tends to be higher than competitors because of its lower out-of-pocket costs for members and increased benefit levels.

Now what

Clover's direct contracting program targeting the original Medicare program could help boost its fortunes going forward. The company expects to sign up between 70,000 and 100,000 Medicare beneficiaries by the end of 2021. If it reaches this goal, the program will enable Clover to at least double its Medicare Advantage membership.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Clover Health Investments. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Clover Health Investments, Corp. Stock Quote
Clover Health Investments, Corp.
CLOV
$3.30 (6.11%) $0.19

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
389%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.